Loading…
Based on limited metadata with no full letter text available, this warning letter was issued to Pfizer Healthcare India Private Limited, a pharmaceutical company, on March 25, 2020. While the specific violations cannot be determined without access to the complete letter content, the warning relates to drug products under FDA jurisdiction. The letter's specific regulatory focus and violation details remain unknown due to unavailable subject line information and issuing office designation.